Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common stock ("Common Shares")
-
Shares outstanding
-
212,883,456
-
Total 13F shares
-
5,006,746
-
Share change
-
+377,574
-
Total reported value
-
$117,752,025
-
Price per share
-
$23.52
-
Number of holders
-
36
-
Value change
-
+$9,256,074
-
Number of buys
-
25
-
Number of sells
-
14
Institutional Holders of OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) as of Q4 2014
As of 31 Dec 2014,
OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,006,746 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, Capital Research Global Investors, RS INVESTMENT MANAGEMENT CO LLC, Pentwater Capital Management LP, FEDERATED INVESTORS INC /PA/, FMR LLC, BlackRock Fund Advisors, PRINCIPAL FINANCIAL GROUP INC, SABBY MANAGEMENT, LLC, and DEUTSCHE BANK AG\.
This page lists
36
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.